Assessing toxicity of mixtures: The search for economical study designs

Human and Ecological Risk Assessment

Volumn 8, Issue 2, 2002, Pages 305-326

  Price, Bertram ^a,e   Borgert, Christopher J ^b,c   Wells, Christopher S ^a   Simon, Glenn S ^d  

^a Price Associates   (United States)

^b Applied Pharmacology and Toxicology Inc   (United States)

^c University of Florida College of Veterinary Medicine   (United States)

^d Rhodia Inc   (United States)

^e Price Associates Inc   (United States)

Author keywords

Chemical interactions; Chemical mixtures; Drug interactions; Health risk assessment; Statistical analysis; Study design

Indexed keywords

EID: 2342543692     PISSN: 10807039     EISSN: None     Source Type: Journal    
DOI: 10.1080/20028091056935     Document Type: Conference Paper

References (24)

1. Berenbaum MC. 1989. What is synergy? [published erratum appears in Pharmacol Rev (1990) 41(3):422]. Pharmacol Rev 41:93-141
2. Bliss CI. 1939. The toxicity of poisons applied jointly. Ann Appl Biol 26:585-615
3. Borgert CJ, Price B, Wells C, et al. 2001. Evaluating chemical interaction studies for mixture risk assessment. Human Ecol Risk Assess 7(2):259-306
4. Box EP, Hunter JS, and Hunter WG. 1978. Statistics for Experimenters: An Introduction to Design, Data Analysis, and Model Building. Wiley & Sons, NY, NY, USA
5. Crump K. 1995. Calculation of benchmark doses from continuous data. Risk Anal 15(1):79-89
6. Gart J, Krewski D, Lee P, et al. 1986. Statistical Methods in Cancer Research Volume III - The Design and Analysis of Long-term Animal Experiments. International Agency for Research on Cancer (IARC), Lyon, France
7. Gennings C. 1995. An efficient experimental design for detecting departure from additivity in mixtures of many chemicals. Toxicology 105:189-97
8. Gennings C, Carter WHJr, Campbell ED, et al. 1990. Isobolographic characterization of drug interactions incorporating biological variability. J Pharmacol Exp Ther 252(1):208-17
9. Gennings C and Schwartz P. 1998. Combination threshold models with design optimization along fixed-ratio rays. J Agricultural, Biol, and Environ Stat 3(1):1-16
10. Greco WR, Bravo G, and Parsons JC. 1995. The search for synergy: a critical review from a response surface perspective. Pharmacol Rev 47:331-85
11. Kissin I, Mason JO, and Bradley ELJr. 1987. Morphine and fentanyl hypnotic interactions with thiopental. Anesthesiology 67:331-5
12. Kortenkamp A and Altenburger R. 1998. Synergisms with mixtures of xenoestrogens: A reevaluation using the method of isoboles. Science Total Environ 221:59-73
13. Levasseur LM, Greco WR, Rustum YM, et al. 1997. Combined action of paclitaxel and cisplatin against wildtype and resistant human ovarian carcinoma cells. Cancer Chemother Pharmacol 40:495-505
14. Loewe S and Muischnek H. 1926. Effect of combinations: mathematical basis of problem. Arch Exp Pathol Pharmakol 114:313-26
15. Miller R. 1995. Simultaneous Statistical Inference. Springer-Verlag, NY, NY, USA
16. Myers R and Montgomery D. 1995. Response Surface Methodology: Process and Product Optimization Using Designed Experiments. Wiley & Sons, NY, NY, USA
17. Poch G, Reiffenstein RJ, and Baer HP. 1995a. Quantitative estimation of potentiation and antagonism by dose ratios corrected for slopes of dose-response curves deviating from one. J Pharmacol Toxicol Methods 33(4):197-204
18. Poch G, Reiffenstein RJ, Kock P, et al. 1995b. Uniform characterization of potentiation in simple and complex situations when agents bind to different molecular sites. Can J Physiol Pharmacol 73:1574-81
19. Rotnitzsky A and Jewell N. 1990. Hypothesis testing of regression parameters in semiparametric generalized linear models for cluster correlated data. Biometrika 7:485-97
20. Tallarida RJ. 1992. Statistical analysis of drug combinations for synergism [published erratum appears in Pain (1993) 53(3):365] [see comments]. Pain 49:93-7
21. Taylor MS, Setzer RW, and DeMarini DM. 1995. Examination of the additivity assumption using the spiral and standard Salmonella assays to evaluate binary combinations of mutagens. Mutat Res 335:1-14
22. Unkelbach HD. 1992. What does the term "non-interactive" mean? Arch Complex Environ Studies 4:29-34
23. USEPA (U.S. Environmental Protection Agency). 1996. Benchmark Dose Technical Guidance Document. EPA/600/P-96/002A. External review Draft. Washington, DC, USA. August 9
24. USEPA (U.S. Environmental Protection Agency). 1999. Guidance for Conducting Health Risk Assessment of Chemical Mixtures. NCEA-C-0148. External Scientific Peer Review Draft. Washington, DC, USA. April